Lilly’s new GLP-1 medication, which is called Foundayo, can be taken once daily at anytime. It will compete against the Wegovy pill.
Lilly’s new GLP-1 medication, which is called Foundayo, can be taken once daily at anytime. It will compete against the Wegovy pill.
Same desk, different stories
Anthropic and DoD are in a battle over the acceptable military use of AI models. The case highlights tensions between AI safety, ethics and national security.
“I assumed that uploading documents to a secure vault meant they would be handled safely.”
Precious metals trading desks around the world had their best year ever in 2025 as dramatic dislocations and surging trading volumes provided more opportunities than ever to make money.
Repealing the HMO Act is not on any politician’s agenda. But perhaps a better regulated, less heavily profit-oriented system of multiple payers could work in the U.S.
Nike warned that its turnaround is taking longer than it expected, leading three Wall Street banks to downgrade the stock as investors lose patience.
Accor SA has signed a memorandum of understanding to sell its stake in Essendi to a consortium including Blackstone Inc. for up to €975 million ($1.1 billion).